Development of a Pre‐assembled Through‐Bond Energy Transfer (TBET) Fluorescent Probe for Ratiometric Sensing of Anticancer Platinum(ll) Complexes

Fluorescence microscopy has emerged as an attractive technique to probe the intracellular processing of Pt‐based anticancer compounds. Herein, we reported the first through‐bond energy transfer (TBET) fluorescent probe NPR1 designed for sensitive detection and quantitation of PtII complexes. The novel TBET probe was successfully applied for ratiometric fluorescence imaging of anticancer PtII complexes such as cisplatin and JM118 in cells. Capitalizing on the ability of the probe to discriminate between PtII complexes and their PtIV derivatives, the probe was further applied to study the activation of PtIV prodrug complexes that are known to release active PtII species after intracellular reduction. Pt(II)‐selective TBET probe: A novel TBET‐based fluorescent probe was developed for ratiometric sensing of anticancer platinum(II) drugs. By exploiting the difference in chemical reactivity of platinum(IV) and platinum(II) complexes, the probe was applied to monitor the intracellular activation of platinum(IV) prodrug complexes in biological systems.